Ona Therapeutics Raises $86.6 Million Series B co-led by Columbus Venture Parrners and Mérieux Equity Partners to Advance First-in-Class ADCs into Clinical Development

by Columbus Venture Partners

The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...

Read more

CDTI and the EIF invest €74.7 million in the Asabys Innvierte Tech Transfer fund

by CDTI Innovación

The Asabys Innvierte Tech Transfer FCRE fund, specialised in biotechnology and medical technologies, will invest in the creation and development of innovative companies in the field of deep-tech appli...

Read more

CDTI invests, together with Asabys and AdBio Partners, in Orikine Bio

by CDTI Innovación

Orikine Bio develops therapies capable of 'reprogramming' the immune system, similar to how software engineers rewrite faulty code to repair computer systems.

Read more

Asabys-backed Oriva Therapeutics launches to advance novel treatments for women’s health

by Asabys Partners

Oriva Therapeutics, a women’s health company developing first-in-class and best-in-class approaches to treat chronic, prevalent conditions affecting women, announced today its incorporation, as well...

Read more

Qida raises €37 million to accelerate its expansion in the home care sector

by Institut Català de Finances (ICF)

The round was led by French investment firm Quadrille Capital and included the participation of Asabys Partners, Cofides, the Institut Català de Finances, and Endeavor Catalyst. Existing shareholders...

Read more

CDTI Innovación invests in Ona Therapeutics, together with five co-investors

by CDTI Innovación

Ona Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...

Read more

AltamarCAM and Asabys agree to integrate Aliath, their life sciences unit, into Asabys

by AltamarCAM Partners

As part of this agreement, the Alta Life Sciences Spain I FCR fund will be co-managed by both firms. Asabys’ founding partners, Clara Campàs and Josep Sanfeliu, will join the Fund’s Investment Co...

Read more

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

by Asabys Partners

The Series B financing was co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors: New Enterprise Associates, UCB ...

Read more

Biotech firm Deepull raises €50 million in round led by Columbus Venture partners

by Columbus Venture Partners

The round was co-led by prominent investors Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners. The financing round also had strong participation from existing investors Asabys...

Read more

Three Asabys-Backed Biotechs Featured in Nature, Showcasing Spain's Scientific Innovation

by Asabys Partners

Nature, the world's leading scientific journal, has spotlighted three Barcelona-based biotech startups, Ona Therapeutics, Nuage Therapeutics, and SpliceBio, in a recent article highlighting Spain's bu...

Read more

Asabys invests in €77.7 million round of Augustine Therapeutics

by Asabys Partners

The oversubscribed financing was co-led by Novo Holdings and Jeito Capital, supported by existing investors Asabys Partners, who led an initial EUR 17.5 million closing in 2024, Eli Lilly and Company,...

Read more

El CDTI invierte junto con Ysios Capital y Asabys Partners en Anaconda Biomed, empresa de dispositivos médicos neurovasculares

by CDTI Innovación

Con un impacto social y económico significativo, el ictus representa un desafío crítico a nivel global. Según datos recientes, el ictus afectará al 25% de los adultos mayores de 25 años a lo lar...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Citring closes a €920,000 funding roun...

by Faraday Venture Partners

Citring began operations in late 2017 and passed through Lanzadera, on...

Photos Stream